Rocket One Inc. Interest Income, Securities, Operating, Taxable
Rocket One Inc. (RKTO) reported Interest Income, Securities, Operating, Taxable of $65.80 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeSecuritiesTaxable · last filed 2023-03-31
- Rocket One Inc. interest income, securities, operating, taxable for fiscal 2022 was $65.80M, a 193.75% increase from fiscal 2021.
- Rocket One Inc. interest income, securities, operating, taxable for fiscal 2021 was $22.40M.
| Period end | Interest Income, Securities, Operating, Taxable 12 month |
|---|---|
| 2022-12-31 | $65.80M 10-K · filed 2023-03-31 |
| 2021-12-31 | $22.40M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |